glutathione parkinson& 39

glutathione parkinson& 39 Revamping Parkinson's disease therapy using PLGA-based drug delivery systems Enhanced accumulation of reduced glutathione

Name: glutathione parkinson& 39 Revamping Parkinson's disease therapy using PLGA-based drug delivery systems Enhanced accumulation of reduced glutathione
Brand: reganhouse.co.nz
SKU: 51994017185
Price: 20.64 USD
Availability: InStock
Rating: 4.1008 (26 reviews)

Enhanced accumulation of reduced glutathione by Scopoletin improves survivability of dopaminergic neurons in Parkinson's model Cell Death & Disease Irisin inhibits dopaminergic neuron lactate metabolism and repairs mitochondrial function to alleviate Parkinson's disease by activating SIRT1 signaling pathway Communications Biology Parkinson's Disease Treatment IV Glutathione for Parkinson's Parkinson's Disease: The Epidemiology, Risk Factors, Molecular Pathogenesis, Prevention, and Therapy PMC Frontiers Metabolic Parkinson's disease Frontiers Recent advances in nanotechnology for Parkinson's disease: diagnosis, treatment, and future perspectives

SKU: 51994017185 · From reganhouse.co.nz

4.1

USD20.64 USD65.64

Pay in 4 interest-free payments of $5.16 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 5 - Aug 10

Description

[DOI] [PMC free article] [PubMed] [Google Scholar] Lok J, Leung W, Zhao S, Pallast S, van Leyen K, Guo S, Wang X, Yalcin A, Lo EH (2011) Gammaglutamylcysteine ethyl ester protects cerebral endothelial cells during injury and decreases blood-brain barrier permeability after experimental brain trauma